On March 22, 2010
Surprise FDA Approvals of Rejected Drugs Are No Sign of Mercy
The FDA delivered what looks to be about the fourth surprise approval recently, green-lighting Somaxon’s twice-rejected sleep drug Silenor (doxepin).
No tags for this post.
0 Comments